Related Experiment Video
Updated: May 4, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Implementation of an order set to adhere to national patient safety goals for warfarin therapy
Sarah Nisly1, Erin D Shiltz2, Vanessa Vanarsdale3
1Clinical Pharmacist, Internal Medicine, Indiana University Health, Methodist Hospital, and Assistant Professor, Department of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, Indianapolis, Indiana;
Insights
Implementing a warfarin order set significantly improved adherence to laboratory monitoring and patient education, enhancing safety for anticoagulant therapy. This initiative supports compliance with National Patient Safety Goal 03.05.01.
Area of Science:
- Clinical Pharmacy
- Patient Safety
- Pharmacoeconomics
Background:
- The Joint Commission mandated National Patient Safety Goal (NPSG) 03.05.01 in 2009 to mitigate risks associated with anticoagulant therapy.
- Patient harm from anticoagulant medications necessitates strict adherence to safety protocols.
Purpose of the Study:
- To evaluate the impact of a warfarin order set on adherence to laboratory monitoring and patient safety protocols.
- To assess improvements in patient education and discharge planning for warfarin patients.
Main Methods:
- A retrospective chart review was performed on 707 inpatients receiving warfarin.
- Data were collected pre and post the implementation of a warfarin order set between January 2008 and July 2011.
- Primary endpoint: overall adherence to laboratory monitoring; Secondary endpoints: compliance with individual parameters, patient education, and follow-up arrangements.
Main Results:
- Overall adherence to laboratory monitoring significantly increased from 71.8% to 87.5% (OR, 2.76; P < .001).
- Improvements were also observed in patient education completion prior to discharge.
- Appropriate follow-up arrangements documented at discharge also showed positive trends.
Conclusions:
- Implementation of a warfarin order set enhances adherence to policies and procedures for NPSG 03.05.01.
- Pharmacy-led monitoring, education, and follow-up arrangements contribute to successful patient safety parameter completion.
Background:
In 2009, The Joint Commission mandated full compliance with National Patient Safety Goal (NPSG) 03.05.01 to reduce the likelihood of patient harm associated with anticoagulant therapy.
Methods:
We conducted a retrospective chart review of inpatients receiving warfarin at Methodist Hospital pre and post implementation of a warfarin order set between January 2008 and July 2011. The primary endpoint of this study was overall adherence to laboratory monitoring. Secondary endpoints included compliance with individual laboratory parameters, percentage of patient educational sessions completed prior to discharge, and percentage of appropriate follow-up arrangements documented on discharge.
Results:
A total of 707 patients were assessed. Overall adherence to laboratory monitoring parameters significantly improved from 71.8% to 87.5% (odds ratio [OR], 2.76; 95% CI, 1.87- 4.07; P < .001). Additional improvements were seen in patient education prior to discharge, and appropriate follow-up arrangements were documented at discharge.
Conclusions:
This analysis demonstrates that implementation of an order set assists in adherence to policies and procedures designed to address the NPSG 03.05.01. Additionally, pharmacy involvement in monitoring, educating, and arranging for follow-up may lead to successful completion of these parameters.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Therapeutic Drug Monitoring: Affecting Factors

